-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Aldeyra Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2013 to Q2 2024.
- Aldeyra Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 59.4M shares, a 1.06% increase year-over-year.
- Aldeyra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 58.9M shares, a 0.92% increase from 2022.
- Aldeyra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 58.4M shares, a 8.08% increase from 2021.
- Aldeyra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 54M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)